| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $118.7M | -5.0% |
| R&D Expense | $1.7M | -55.8% |
| SG&A Expense | $69.0M | -8.1% |
| Operating Income | -$21.5M | +12.0% |
| Pre-tax Income | -$29.9M | -39.1% |
| Income Tax | $435K | +736.5% |
| Net Income | -$30.4M | -40.7% |
| EPS (Basic) | -$4.74 | -1960.9% |
| EPS (Diluted) | -$4.74 | -1960.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.2M | -79.8% |
| Short-term Investments | $53.2M | +7.5% |
| Accounts Receivable | $120.1M | +121.9% |
| Inventory | $24.1M | -37.0% |
| Current Assets | $216.6M | +7.0% |
| Total Assets | $267.0M | -6.2% |
| Current Liabilities | $127.5M | +11.2% |
| Long-term Debt |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.2M | -206.7% |
| Investing Cash Flow | -$12.0M | +75.5% |
| Financing Cash Flow | -$189K | +46.0% |
| $39.1M |
| +0.8% |
| Total Liabilities | $173.0M | +5.7% |
| Stockholders' Equity | $94.0M | -22.4% |